MEDICAEncuentre a Sobel en MEDICA 2026Düsseldorf, 16–19 nov.Reserve una reunión →Reservar
Medical Devices • ISO 10993-1:2025 Update • Biological Evaluation

Is your ISO 10993-1 strategy ready for the 2025 update?

The ISO 10993-1:2025 update can affect how your biological evaluation, materials information, exposure rationale and testing strategy are documented for medical device submissions.

Sobel helps medical device companies review existing biological evaluation documentation, identify update gaps and define the next technical-regulatory step based on the device, body contact, materials, evidence and target market.

ISO 10993-1:2025 Assessment
Start your update assessment ~60 seconds

Answer 3 quick questions so the right technical-regulatory specialist can review your update scenario.

Step 1 of 4

What do you need to update or review right now?
Which situation best describes your device or portfolio?
What do you already have available for review?
Where should we send your update assessment?

Please enter your name.

Please enter a valid email address.

Please enter your phone number.

Please enter your company.

Technical review ISO 10993 expertise Confidential

Request received

Your request will be reviewed by a technical-regulatory specialist, and we will follow up with the next steps.

Want a head start? Have these ready if you can:
  • Device type, body contact and intended use
  • Current biological evaluation documentation
  • Available ISO 10993 reports, test data or rationale
You’ll hear from a technical-regulatory specialist — not an automated sequence — Reviewed by a specialist.
  • ISO 10993-1:2025 update assessmentUnderstand whether your current documentation may need updates before the next regulatory step.
  • Reviewed by a specialistYour update scenario is reviewed by a technical-regulatory team, not an automated sequence.
  • Your technical information stays confidentialTechnical information is handled only to understand your update needs and provide relevant support.

Not sure what the ISO 10993-1:2025 update means for your device? Start with an update assessment · Read the FAQ · Request specialist support

Trusted technical-regulatory support for medical device companies

B. Braun Fresenius Kabi Dentsply Sirona Hypera Pharma Aché Baruel Surya Brasil Pasteur Cosmiatria Supera Farma Avenca Cosméticos Teuto ADV Farma S.I.N. Implant System

Highly qualified technical-regulatory team

Specialized support to interpret ISO 10993-1:2025 changes with technical and regulatory perspective.

ISO 10993-1:2025 review with context

Existing documentation, biological endpoints and technical rationale are reviewed in relation to the device and target market.

Built for update readiness

Assessment designed to clarify what may need to be updated before submission, audit, renewal or regulatory response.

Is this update assessment for you?

Built for medical device companies that need clarity on how ISO 10993-1:2025 may affect their biological evaluation documentation.

For manufacturers, regulatory teams and medical device companies that need to understand whether existing BEP/BER files, test reports and rationales are aligned with the updated ISO 10993-1 approach.

You do not need to know exactly what your biological evaluation needs before contacting us. The initial assessment is designed to help clarify the next technical-regulatory step.

  • You already have ISO 10993 data, test reports or a BER
  • Your team is preparing or updating a medical device submission
  • You are unsure whether existing evidence and rationale remain sufficient
  • You need to update justification, endpoints or technical rationale
  • You received regulatory, auditor or notified body questions
The risk

An outdated biological evaluation strategy can create preventable gaps.

A file that was acceptable under a previous approach may still need review when standards, expectations or documentation logic change — especially before submission, audit or regulatory response.

What often needs review

  • Whether existing ISO 10993 evidence still supports the file
  • Whether endpoints, exposure duration and rationale are documented clearly
  • Whether evidence matches the device, materials and intended use
  • Whether the technical rationale supports the target market and update expectations

What it can cost you

  • Unnecessary testing or repeated documentation work
  • Regulatory, auditor or notified body questions
  • Documentation gaps discovered late
  • Delayed timelines and internal uncertainty
The update assessment

A focused ISO 10993-1:2025 update review before you move forward.

Sobel reviews your current biological evaluation documentation, available evidence and update scenario to help identify what may need to be revised before submission, audit, renewal or regulatory response.

Current file

Current file and ISO 10993 Review

A structured review of your existing biological evaluation documentation and supporting evidence.

  • Existing ISO 10993 data or reports assessed
  • Device, body contact and exposure duration considered
  • Materials and intended use reviewed
  • Potential ISO 10993-1:2025 update gaps identified
  • Relevance to the target market considered
Update path

Technical-Regulatory Update path

A clearer view of what your update path may require.

  • Testing and evidence needs clarified
  • Technical rationale reviewed against the updated approach
  • Documentation updates mapped
  • Submission, audit or response readiness assessed
  • Next technical-regulatory step outlined

Assessment focused on existing files, update gaps and the next technical-regulatory step.

How it works

Start by reviewing what you already have.

You do not need to know exactly what needs to change — that is what the ISO 10993-1:2025 update assessment is designed to clarify.

  1. Share your case Today

    Tell us about your device, body contact, target market and current ISO 10993 documentation.

  2. We review the update impact Reviewed by a specialist

    Our technical-regulatory team reviews your current files, available data, documentation logic and potential update gaps.

  3. We assess the evidence and rationale

    We evaluate whether existing ISO 10993 data, reports and rationale may still support the updated strategy.

  4. We outline the update path

    We help clarify whether your case may require stronger rationale, documentation updates, additional review or regulatory response support.

  5. You move forward with more clarity

    Your team gains a clearer view of what should be updated before the next regulatory step.

Why Sobel

Qualified technical-regulatory support for ISO 10993-1:2025 updates.

Highly qualified team

ISO 10993-1:2025 updates require qualified interpretation. Sobel brings specialized support to review files, gaps and technical rationale with regulatory perspective.

ISO 10993-1:2025 review with context

We review ISO 10993 documentation in relation to the device, materials, body contact, intended use and target market.

Submission-focused assessment

Our review is focused on whether the biological evaluation file can support the next regulatory step under the updated approach.

Clearer decision-making

We help your team understand whether to move forward, strengthen the rationale, revise documentation or consider additional evidence.

What clients say
“We experienced a very friendly, target-oriented service with fast solutions, and we look forward to continuing our work with Sobel.”
Andreas KohlAndraTec
Questions, answered

Frequently asked questions

Yes. Many companies do not know whether the update affects their current files, rationale or evidence strategy. The initial assessment helps identify the most appropriate next step.

Not always. The need for additional testing depends on the device, materials, body contact, intended use, available evidence, documentation quality and regulatory pathway.

In many cases, existing data may still be useful, but it should be reviewed in relation to the specific device, contact type, materials, documentation quality, technical rationale and target market.

Existing documents can be valuable, but they should be assessed for relevance, completeness and alignment with the updated biological evaluation approach.

Sobel provides technical-regulatory consulting support. Our role is to help companies assess update needs, review data, identify gaps and define the next regulatory step.

Device type, body contact, target market, current stage, available ISO 10993 data or reports, current BEP/BER if available, and your main update question.

Yes. Your technical information is handled confidentially and used only to understand your request and provide relevant support.

A technical-regulatory specialist will review your update request and follow up with the most appropriate next steps.

One step from clarity

Not sure what the ISO 10993-1:2025 update means for your device? Start with an update assessment.

Share your current documentation, available evidence and main question. Sobel’s technical-regulatory team will review your scenario and help identify the most appropriate next step.

Start my assessment →

Confidential · Specialist review · Update-focused

Start my assessment →
[contact-form-7 id="c27d3f0" title="Formulario de contacto Popup"]
[contact-form-7 id="c27d3f0" title="Formulario de contacto Popup"]

Boletín

Suscríbete a nuestro boletín para recibir las últimas actualizaciones y opiniones.

Puedes darte de baja en cualquier momento utilizando el enlace que aparece en nuestro boletín.